If Excel is where you track projects, plan budgets, manage clients, or run your side hustle, you already know it’s a powerhouse. But turning rows and columns into real answers—spotting trends, ...

Discover how to create a stunning decorative art piece using wooden Arabic letters and fabric in this step-by-step DIY art tutorial. Watch as intricate calligraphy and textured materials combine with ...

Patients with concurrent malignancies pose significant diagnostic and therapeutic challenges. We report a rare and fatal case of synchronous ovarian mixed germ cell tumor and mast cell leukemia (MCL) ...

ABSTRACT: Background: Basal cell carcinoma (BCC) is the most common form of skin cancer. WHO classifies BCC into subtypes based on histopathological characteristics. Dermoscopy is a valuable tool for ...

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min Wauwatosa could incentivize the ...

Pantone has chosen its 2026 Color of the Year, and depending on how you look at it, it could be colorless — or the reflection of every color. The "color?" White. Cloud Dancer (PANTONE 11-4201) to be ...

President Donald Trump posted a series of anti-immigration messages on Thanksgiving, one of which included a slur. In a Truth Social post, Trump used the "r-word" to describe Minnesota Gov. Tim Walz.

You can get ChatGPT to help you build a nuclear bomb if you simply design the prompt in the form of a poem, according to a new study from researchers in Europe. The study, "Adversarial Poetry as a ...

Durham leaders have approved a rezoning request that will allow Research Triangle Park to become more of a destination hub. Durham County Board of Commissioners voted unanimously on Monday to amend ...

Agios Pharmaceuticals, Inc. (NASDAQ:AGIO) ranks among the most oversold biotech stocks to invest in. On November 20, Leerink Partners upgraded Agios Pharmaceuticals, Inc. (NASDAQ:AGIO) from Market ...

Shares of Agios Pharmaceuticals AGIO tanked about 51% on Wednesday after it reported mixed top-line results from the phase III RISE UP study, which evaluated orally administered Pyrukynd (mitapivat) ...

Aspen Neuroscience’s cash reserves have been fertilized with a $115 million series C fundraise that will enrich the biotech’s ongoing trial of a regenerative cell therapy for Parkinson’s disease. The ...